Search

everythinglearnresearchcommunity

for

Search:↓

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Dupilumab can help regrow hair and improve skin conditions in patients with severe atopic dermatitis and alopecia areata.

Implanting hair-follicle stem cells in mice brains helped repair brain bleeding and reduced brain inflammation.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Stress in mice delays hair growth and treatments blocking substance P can partly reverse this effect.

Doxazosin and finasteride negatively affect sexual function in men with BPH.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Severe sarcoidosis often requires long-term systemic corticosteroids and multidisciplinary care, with most patients improving but some experiencing persistent symptoms or complications.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Certain proteins, caspases-1 and -11, are important in the early development of skin inflammation in mice.

Double-stranded RNA causes inflammation in hair follicle cells, which may help understand and treat alopecia areata.

ILC1 cells contribute to hair loss in alopecia areata.

Damage to skin releases dsRNA, which activates TLR3 and helps in skin and hair follicle regeneration.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

The African spiny mouse can fully regenerate its muscle without scarring, unlike the common house mouse.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Myc changes chromatin in stem cells, causing them to leave their niche.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

New treatments for hair loss are showing promise due to better understanding of genetics and the immune system.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

One minoxidil-sensitive potassium channel exists in human hair follicles.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

Minoxidil prevents serotonin loss from MDMA by affecting potassium channels and increasing Akt phosphorylation.

Male hormones indirectly affect skin cell development by increasing growth factor levels from skin fibroblasts.

Micro-current stimulation may promote hair growth more effectively than standard treatments.